The NewProt protein engineering portal is a one-stop-shop for in silico protein engineering. It gives access to a large number of servers that compute a wide variety of protein structure characteristics supporting work on the modification of proteins through the introduction of (multiple) point mutations. The results can be inspected through multiple visualizers. The HOPE software is included to indicate mutations with possible undesired side effects. The Hotspot Wizard software is embedded for the design of mutations that modify a proteins' activity, specificity, or stability. The NewProt portal is freely accessible at http://newprot.cmbi.umcn.nl/ and http://newprot.fluidops.net/.
Introduction
Proteins are the workhorses of life, and the possibility to modify their amino acid sequence has generated opportunities in fields that range from basic science, like understanding the fabric of life, to applied science, like the more efficient and safer production of food, industrial enzymes, detergents, shampoos, etc. Knowledge about the three dimensional structure of proteins has proven important in all these fields Lutz, 2009 & .
Although the three dimensional structure of a protein is determined by its sequence (Anfinsen, 1973) , it is also true that many different sequences will lead to the same fold, and even the mutation of a large number of residues often will neither destroy the fold nor the protein's function (Pavlova et al., 2009; Jochens and Bornscheuer, 2010; Bednar et al., 2015; Sun et al., 2015) .
Obviously, if an enzyme's catalytic site residues are mutated, it will lose its function, but it is not often observed that changing one residue will destroy a protein's structural integrity. With amyloid proteins as only known exception, it was so far not observed that a single mutation gives a protein another stable fold (Dalal and Regan, 2000; Singh and Udgaonkar, 2016) .
Evolution has used billions of years to generate enzymes that function efficiently. Today, the use of (modified) enzymes to improve industrial processes comes with many advantages. They are efficient, non-toxic and biodegradable. Enzymes usually show high chemo-, regio-and stereo-selectivity, and usually are active in the aqueous phase at physiological pH, and produce hardly any chemical waste products. One of the aims of biotechnology is changing the function of an enzyme to give it new characteristics like improved catalytic potency, thermal or pH stability, solvent tolerance, substrate specificity, stereo-selectivity, etc.
The past decades have brought many successful examples of protein engineering in which lab work and bioinformatics went hand-in-hand. In 2010, Savile et al. (2010) developed an enzymatic method for the synthesis of the diabetes drug sitagliptin using a transaminase. Starting from an enzyme that had the required catalytic machinery, but lacked activity towards the substrate, they used a combination of modeling and directed mutagenesis to enlarge the protein's binding site and its activity while also improving its stability under process conditions. Recently, a (S)-selective amine transaminases was created for the efficient and highly stereo-selective synthesis of bulky chiral amines that are useful as building blocks for pharmaceutical intermediates (Pavlidis et al., 2016) . The starting enzyme showed almost no detectable activity but after the introduction of only four mutations that were identified through multiple sequence alignment analyses and 3D modeling, an 8.900-fold improvement could be achieved. Khoury et al. (2009) used their Iterative Protein Redesign and Optimisation (IPRO) (Saraf et al., 2006) system to alter the co-factor specificity of Candida boidinii xylose reductase from NADPH to NADH. Pavlova et al. (2009) mutated tunnel lining residues in a haloalkane dehalogenase and improved its catalytic activity 30-times towards the recalcitrant and toxic halogenated compound 1,2,3-trichloropropane.
Biotechnology and biocatalysis have already been used for decades to produce desired compounds for chemistry as well as important chiral building blocks that serve as precursors for advanced pharmaceutical intermediates. Today's in vitro protein engineering tools allow us to rapidly evolve enzyme functions towards a desired property (Kazlauskas and Bornscheuer, 2009) . Despite the long list of successful protein engineering projects, of which only a few were summarized in the previous paragraphs, most enzyme improvement projects still are trial-and-error based, and what is left to do is the design of good in silico tools to reduce the number of protein variants that actually need to be produced and purified to a number that can be tested in just one or a few experiments. Table 1 lists some web-based facilities that predict the effect of mutations on protein function. Other webservers that might not all be equally applicable to mutant prediction, but that might nevertheless be interesting for in silico protein engineering can, for example, be found at swift. cmbi.ru.nl, mordred.bioc.cam.ac.uk/~sdm/links.php, www.expasy.org or http://www.oxfordjournals.org/our_journals/nar/webserver/c/.
Despite the existence of many servers that, in principle, predict the mutations needed to modify an enzyme's function as desired, the protein engineer in practice spends much time in front of the computer using molecular visualization software, a multiple sequence alignment, the output of several web server(s) and lists of residue characteristics. We have produced the NewProt portal that provides a one-stop-shop to obtain all this information in an integrated fashion. The portal includes the Hotspot Wizard that designs mutations that are safe (i.e. do not disrupt the protein structure) and at the same time have a good chance to lead to altered catalytic properties and improved stability (Pavelka et al., 2009) .
Often, mutations that achieve an improvement in one of the protein's characteristics cause side effects by modifying another characteristic too; e.g. a thermostabilising mutation might remove an essential post translational modification site. In one example, protein engineering was used to improve the stereo-selectivity of an esterase. The triple variant found with substantially improved selectivity unfortunately could hardly be expressed in E. coli. Therefore, a double mutant was created, which had the desired stereo-selectivity and could be expressed similar to the wild-type esterase (Schmidt et al., 2006) . In human genetics a single amino acid substitution often can give rise to a disease (McKusick, 1996) . HOPE helps the user understand how one mutational change can cause a disease phenotype (Venselaar et al., 2010) and in the NewProt portal it is used to analyze undesired side effects of predicted mutations. The one esterase mutation that caused the low expression indeed was judged deleterious by the HOPE software.
Methods
The NewProt portal is based on the Information Workbench (Haase et al., 2011) . It provides an environment that allows for easy interaction with all NewProt resources. Serving as a platform for Linked Data, the Information Workbench allows for collaboration, services, integration of public as well as private data and services, and analytics on those data. Users benefit from a unified view of both the data and the integrated resources. The architecture of the portal is divided into three concentric layers surrounding the core platform: The portal can communicate with commercial products for which the portal user has a license. In this case, the results from the one portal can seamlessly be transferred to the other. Open source or freely available emulators are available for commercial products for which a user might not have a licence. Emulators, obviously, do not achieve the performance of the software they emulate, but ensure an uninterrupted workflow for the whole system. Figure 1 illustrates the Graphical User Interface (GUI). The user defines a project by either providing the UniProt accession code or a FASTA sequence of the protein for which a homology model will then be built automatically (Krieger et al., 2009) or obtained from the Protein Model Portal (PMP) (Haas et al., 2013) . Alternatively, the NewProt search facilities can be used to find the structure of the protein or a close homolog in the PDB. The user can also provide a self-generated protein structure in PDB format. The portal will create a new project page on which the user collects protein structure information. MRS (Hekkelman and Vriend, 2005) is integrated in the portal to provide easy access to a large number of databases with relevance for protein engineering. The structure data can be sent to a whole series of web services ( Table 2 ) that calculate mutation hotspots, variability, residue contacts, the chance that a mutation to proline at this position will stabilize the protein, salt bridges that might be formed or broken, effects on contacts with ions, etc. Each structure/model on the project page links to its own page. On these pages, structural calculations by WHAT IF and HOTSPOT WIZARD can be performed. HOTSPOT WIZARD indicates those residues that can be mutated in order to change specificity or activity without compromising its function. The WHAT IF servers calculate a wide range of residue features, such as contacts to metals or ligands, salt bridges, the possibility to mutate the residue into a proline and the variability of the residue in a multiple sequence alignment. Users can follow a link to a corresponding 3DM alignment (or when they do not have the required license they can use the VASE 3DM-emulator at http://www.cmbi.ru.nl/vase/). Numerical results are shown in an interactive table and also can be visualized with either YASARA or JMOL. The YASARA scene files created by the portal can be viewed with the freely available YASARA View (Krieger and Vriend, 2014) . Mutation reports can be created by Project HOPE (Venselaar et al., 2010) . The introduction page of the portal provides an overview of all projects shared with (or by) the user, administration options and an extensive manual as well as a series of videos explaining aspects of its use. Its modular design makes that it will be easy to add extensions, and users can use the NewProt feedback mechanism to ask for more computational methods to be included. The presently included facilities are being maintained by their authors and undergo regular revisions. In case any of the external facilities ceases to be accessible, the CMBI will provide an emulator for it.
Results
The identification of novel biocatalysts is difficult if the desired activity is not the natural function of the protein. By exploring the structural determinants responsible for that desired activity, valuable information for the identification and discrimination of potential modifications can be obtained. And this is exactly where the NewProt portal can help. The portal has been tested extensively by using it in a series of protein engineering projects. A few of these projects are listed here, but many more have been published elsewhere already (Genz et al., 2015; Nobili et al., 2015a,b; Skalden et al., 2015; Steffen-Munsberg et al., 2015) . The industrial applicability of amine transaminases (ATAs) hitherto had been limited by the complexity of their substrate binding site. The active site of ATAs is located between two monomers and consists of a large and a small binding pocket, of which the latter only provides space for one methyl group. To overcome this problem we can either engineer the active site of the ATAs, or search for transaminases with desired substrate specificities. Four putative ATAs were identified in the Protein Data Bank (PDB) (3HMU, 3I5T, 3GJU and 3FCR) that were studied for applicability in biocatalysis , and functional analyses revealed an arginine in the large binding pocket that is flexible and seems a safe candidate for mutation to obtain dual substrate recognition, which makes them versatile amine transaminases with a substantially different substrate preference from the more prominent α-amino acid transaminases .
A more radical approach to changing the functionality of ATAs is systematic engineering of all active site residues. Based on structure examination with YASARA and sequence analyses through the 3DM-database of pyridoxal 5′-phosphate (PLP)-dependent enzymes from fold class I (Steffen-Munsberg et al., 2015) the amine transaminase from Vibrio fluvialis was selected for a systematic mutagenesis study of its active site residues to expand its substrate scope towards bulky substrates like α-hydroxy and aryl-alkyl ketones (Nobili et al., 2015a) . The residues F85, Y150 and V153 showed most potential and were checked using the NewProt portal. Subsequently, a small, smart library was created containing only amino acids observed at Position 85 in the MSA, all 20 amino acid types at Position 150 and the V153A mutation (with inclusion, of course, of the wild types at all three positions). Two mutations were identified (F85L/V153A and Y150F/V153A) and experimental verification revealed a 30-fold increased activity in the synthesis of (S)-phenylbutylamine and (R)-phenylglycinol. Asymmetric synthesis of these amines was performed resulting in excellent yields and the produced amines have excellent enantiomeric purity of 98%. Valine 153 is a hotspot for the optimization of ATAs from Vibrio fluvialis and Paracoccus denitrificans (Midelfort et al., 2013; Park et al., 2014; Nobili et al., 2015a) . Mutating this valine into alanine creates more space in the substrate binding pocket and thus enables the conversion of bulkier substrates, but it also leads to a decrease in protein stability (unpublished). To elucidate the reasons for this instability this amino acid exchange was studied with help of the NewProt portal. Based on information from the PDB file and the PISA-assembly (Krissinel and Henrick, 2007) , HOPE indicated that mutating this residue might cause instability of the protein structure because of a loss of multimeric contacts. Visual inspection of this position in the crystal structure (PDB: 4E3Q) revealed that the sidechain of V153 indeed directs outwards into a relatively hydrophobic pocket at the surface of the other monomer (Fig. 2) . Further analysis of this V153 position using 3DM (3DM No. 132) revealed that mainly valine (36.6%), serine (40.8%) and threonine (10.3%) are present at this structural position within a 3DM-database containing 1773 aminotransferase sequences (Fig. 3) . This led to the hypothesis that mutation of this residue to a smaller, less hydrophobic residue decreases the strength of the hydrophobic interactions between the two monomers leading to decreased protein stability. However, a small polar residue may theoretically also be accepted in this position due to the presence of several polar residues in the direct 3D environment. Interestingly, Genz et al. showed that variants containing the V153A or V153G mutation indeed showed decreased protein stability, especially when a glycine substitution was present (unpublished).
The idea of targeting residues lining protein access tunnels proved to be a valuable strategy for obtaining enzyme variants. Focused directed evolution of five tunnel residues of the haloalkane dehalogenase DhaA from Rhodococcus rhodochrous showed 32-fold greater activity towards the toxic, anthropogenic pollutant 1,2,3-tricholoropropane than the wild-type enzyme (Pavlova et al., 2009) . Four further mutations gave this same enzyme increased thermal stability (melting temperature T m increased 19°C) and organic co-solvent resistance (half-life in 40% DMSO prolonged 4000-fold; from minutes to weeks) compared to wild type (Koudelakova et al., 2013) . In these two studies, HotSpot Wizard was able to correctly predict three out of five and two out of four mutated positions, respectively.
Conclusions
The NewProt protein engineering portal is a free one-stop-shop for protein structure related computational facilities. It will not tell exactly what to do, but it relieves the protein engineer from many simple household computational chores by providing integrated access a large number of computational facilities, to visualization and to artificial intelligent mutation validation.
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